0001213900-20-035129.txt : 20201104
0001213900-20-035129.hdr.sgml : 20201104
20201104212020
ACCESSION NUMBER: 0001213900-20-035129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201102
FILED AS OF DATE: 20201104
DATE AS OF CHANGE: 20201104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shabahang Shahrokh
CENTRAL INDEX KEY: 0001816754
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39336
FILM NUMBER: 201288382
MAIL ADDRESS:
STREET 1: 11161 ANDERSON STREET
STREET 2: SUITE 105-10014
CITY: LOMA LINDA
STATE: CA
ZIP: 92354
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADiTx Therapeutics, Inc.
CENTRAL INDEX KEY: 0001726711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823204328
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11161 ANDERSON STREET
STREET 2: SUITE 105-10014
CITY: LOMA LINDA
STATE: CA
ZIP: 92354
BUSINESS PHONE: 909-488-0844
MAIL ADDRESS:
STREET 1: 11161 ANDERSON STREET
STREET 2: SUITE 105-10014
CITY: LOMA LINDA
STATE: CA
ZIP: 92354
4
1
ownership.xml
X0306
4
2020-11-02
0
0001726711
ADiTx Therapeutics, Inc.
ADTX
0001816754
Shabahang Shahrokh
C/O ADITX THERAPEUTICS, INC.
11161 ANDERSON STREET, SUITE 105-10014
LOMA LINDA
CA
92354
1
1
0
0
CHIEF INNOVATION OFFICER
Stock Option (Right to Buy)
1.92
2020-11-02
4
A
0
110000
0
A
2030-11-02
Common Stock
110000
110000
D
The options shall vest as to 50% of the total shares on November 2, 2021, after which the remaining 50% of the total shares shall vest in four successive equal quarterly installments.
/s/ Shahrokh Shabahang
2020-11-04